A researcher prepares a sample inside a laboratory at BeiGene Ltd’s research and development centre in Beijing on May 24, 2018. The company made its Hong Kong trading debut in August 2018. Photo: Bloomberg
How Hong Kong can cement its position as a biotech listing hub
2021-05-27T01:15:15-04:00May 27th, 2021|
Related Posts
-
China’s Nio, FAW Group tie up for battery charging, swapping
May 22nd, 2024